New Perspectives in Pharmaceutical Crystallization and Possibilities of Analysis of the Obtained Crystals
A special issue of Crystals (ISSN 2073-4352). This special issue belongs to the section "Biomolecular Crystals".
Deadline for manuscript submissions: closed (30 October 2023) | Viewed by 145
Special Issue Editors
Interests: crystallography; biocrystals; crystal growth; pharmaceutical physics; biophysics; crystal chemistry; crystal physics; biomineralization condensed matter; ADME-TOX analysis; biological macromolecules; X-ray analysis; electron diffraction analysis; neutron diffraction analysis
2. Research Center for Pharmaco-Toxicological Evaluations, Faculty of Pharmacy, Victor Babes University of Medicine and Pharmacy, 2 Eftimie Murgu Street, 300041 Timisoara, Romania
Interests: drug analysis; drug product design and development; analytical technique; magnetic and metallic nanoparticles; polymeric nanoparticles; solid–lipid nanoparticles; drug–cyclodextrin inclusion; complexation; cell biology; biological active compounds; biomedical microbiology; biophysics; biochemistry
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Pharmaceutical crystallization processes can be developed to explore continuous manufacturing in the pharmaceutical industry and are one of many methods to obtain and analyse the physical and chemical properties of crystals. Pharmaceutical crystallization is an important technology within pharmaceutical processes and can be used to determine numerous product properties in the solid‒liquid separation process, which is not only a separation and purification process but also a refining process.
By using pharmaceutical crystallization processes, we can obtain co-crystals too, which are crystalline complexes of active/neutral compounds. Co-crystallization determine the preservation of the intrinsic pharmacological properties of the active ingredients such as the melting point, solubility, and dissolution. Drug‒drug co-crystals represent a promising line of research in given that combined therapies are frequently prescribed for the effective treatment of numerous pathologies, meaning the co-crystals of multiple active compounds might overcome the drawbacks of conventionally combined drugs.
Dr. Mirela Nicolov
Prof. Dr. Codruta Soica
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Crystals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- crystallography
- biocrystals
- crystal growth
- pharmaceutical physics
- crystal chemistry
- crystal physics
- biomineralization condensed matter
- ADME-TOX analysis
- biological macromolecules
- X-ray
- electron diffraction
- neutron diffraction
